Quantitative Ultrasound of the Heel and Some Parameters of Bone Turnover in Patients with Acromegaly
Abstract
Acromegaly caused by growth hormone (GH) hypersecretion is characterized by enhanced skeletal growth and soft tissue enlargement. Insulin-like growth factor-1 (IGF-1) is the main peripheral mediator of GH action and it has a crucial role in the maintenance of a normal bone mass. However, in some patients with acromegaly, secondary osteoporosis is observed, despite the strong anabolic effect of GH and IGF-1 in bones. It is thought to be due to hypogonadism. The bone changes are accompanied by increased turnover. The aim of this study was to assess bone properties by ultrasound and turnover in patients with acromegaly. The study was carried out in 26 patients (13 men, 13 women): 14 with active acromegaly and 12 cured by surgery who had non-active disease. Speed of sound (SOS), broadband ultrasound attenuation (BUA) and their combination Stiffness Index (SI) by quantitative ultrasound (QUS) of the heel, hormonal status, serum osteocalcin (OC) concentration and the urinary excretion of pyridinoline collagen crosslinks (PYR) were all studied. Controls were 20 age- and sex-matched healthy persons. We observed statistically significantly lower QUS values in patients with active disease than in those whose disease was cured. The differences were more pronounced in men. QUS values were lower in the entire group of patients compared with the controls; however, the differences were not statistically significant. Serum OC concentrations and urinary PYR excretion were higher in active dis…
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
GH and IGF-1 stimulate proliferation, differentiation, and extracellular matrix production in osteoblastic cells, and also promote osteoclast recruitment and bone resorption activity.
“GH and its main peripheral mediator insulin-like growth factor-1 (IGF-1) stimulate proliferation, differentiation, and extracellular matrix production in osteoblastic cells. GH and IGF-1 also promote osteoclast recruitment and bone resorption activity [27–30].”
From Pituitary Disorders and Osteoporosis (2015) · cites this paper as [28]
Conflicting data on bone mineral density in acromegaly might be related to gonadal status, different skeletal sites measured, various techniques employed, subject's gender, age, and activity of the disease.
“Conflicting data on bone mineral density might be related to gonadal status, different skeletal sites being measured, various techniques employed, subject's gender, age, and activity of the disease [28, 36, 38].”
From Pituitary Disorders and Osteoporosis (2015) · cites this paper as [28]
Indicators of bone resorption such as urinary hydroxyproline/creatinine, urinary type I collagen cross-linked N-telopeptide, and serum C-terminal collagen type I cross-links are in higher concentrations in acromegaly than in controls.
“Indicators of bone resorption such as urinary hydroxyproline/creatinine, urinary type I collagen cross-linked N-telopeptide, and serum C-terminal collagen type I cross-links are in higher concentrations than in controls [28, 29, 35, 40, 43].”
From Pituitary Disorders and Osteoporosis (2015) · cites this paper as [28]
Impaired gonadal status including hypogonadism and hyperprolactinemia is thought to be a cause of BMD decline in acromegaly.
“Impaired gonadal status including hypogonadism and hyperprolactinemia is thought to be a cause of BMD decline [28, 34].”
From Pituitary Disorders and Osteoporosis (2015) · cites this paper as [28]
Osteocalcin, a specific marker of bone formation, is elevated in subjects with active acromegaly.
“A specific marker of bone formation, osteocalcin, is elevated in subjects with active disease [28, 29, 35, 40, 43].”
From Pituitary Disorders and Osteoporosis (2015) · cites this paper as [28]
In patients with acromegaly, bone turnover is increased.
“It is well known that in patients with acromegaly bone turnover is increased [28, 29, 35].”
From Pituitary Disorders and Osteoporosis (2015) · cites this paper as [28]
Cites
Ohlsson, C., Bengtsson, B., Isaksson, O. G. P., Andreassen, T. T., & Slootweg, M. C. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.1.0324 · Cited by 863 · see citing works
Delmas, P. D., Schlemmer, A., Gineyts, É., Riis, B. J., & Christiansen, C. (1991) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650060615 · Cited by 301 · see citing works
Gregg, E. W., Kriska, A. M., Salamone, L. M., Roberts, M., Aderson, S. J., Ferrell, R. E., Kuller, L. H., & Cauley, J. A. (1997) · Osteoporosis International · doi:10.1007/bf01623682 · Cited by 243 · see citing works
Calcaneal ultrasonic measurements discriminate hip fracture independently of bone mass
Turner, C. H., Peacock, M., Timmerman, L. A., Neal, J. M., & Johnston, C. C. (1995) · Osteoporosis International · doi:10.1007/bf01623314 · Cited by 184 · see citing works
Faulkner, K. G., McClung, M. R., Coleman, L. J., & Kingston-Sandah, E. (1994) · Osteoporosis International · doi:10.1007/bf02352260 · Cited by 178 · see citing works
Diamond, T., Nery, L., & Posen, S. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-111-7-567 · Cited by 147 · see citing works
Biochemical assessment of bone formation and resorption in acromegaly
Ezzat, S., Melmed, S. K., Endres, D. B., Eyre, D. W., & Singer, F. R. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.76.6.1452 · Cited by 138 · see citing works
Yamaga, A., Taga, M., MINAGUCHI, H., & Sato, K. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.2.8636299 · Cited by 130 · see citing works
Bone mineral density and parameters of bone metabolism in patients with acromegaly
Kotzmann, H., Bernecker, P., Hübsch, P., Pietschmann, P., Woloszczuk, W., Svoboda, T., Geyer, G., & Luger, A. (1993) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650080410 · Cited by 98 · see citing works
Kann, P. H., Piepkorn, B., Schehler, B., Andreas, J., Lotz, J., Prellwitz, W., & Beyer, J. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00439.x · Cited by 93 · see citing works
Gonadal status is an important determinant of bone density in acromegaly
Lesse, Fraser, Farquharson, Hipkin, & Vora (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00349.x · Cited by 90 · see citing works
Bravenboer, N., Holzmann, P. J., de Boer, H., Roos, J. C., van der Veen, E. A., & Lips, P. T. A. M. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.6.1818 · Cited by 82 · see citing works
Bone mineral density of the axial skeleton in acromegaly.
Ho, P. J., Fig, L. M., Barkan, A. L., & Shapiro, B. (1992) · PubMed · Cited by 66 · see citing works
The effect of ankle oedema on bone ultrasound assessment at the heel
Johansen, A., & Stone, M. D. (1997) · Osteoporosis International · doi:10.1007/bf01623459 · Cited by 66 · see citing works
Correlation among plasma osteocalcin, growth hormone, and somatomedin C in acromegaly
de la Piedra, C., Carbó, E., Larrañaga, J., Castro, N., Horcajada, C., Rapado, A., & Pombo, J. L. H. (1988) · Calcified Tissue International · doi:10.1007/bf02555167 · Cited by 59 · see citing works
Gonnelli, S., Montagnani, A., Cepollaro, C., Monaco, R. D., Gennari, L., Rossi, B., Pacini, S., & Gennari, C. (2000) · Osteoporosis International · doi:10.1007/s001980050289 · Cited by 43 · see citing works
Quantitative Ultrasound of Bone and Markers of Bone Turnover in Cushing's Syndrome
Cortet, B., Cortet, C., Blanckaert, F., D’Herbomez, M., Marchandise, X., Wemeau, J. L., Decoulx, M., & Dewailly, D. (2001) · Osteoporosis International · doi:10.1007/s001980170143 · Cited by 41 · see citing works
Serum bone Gla protein as a marker of bone turnover in acromegaly
Marazuela, M., Astigarraga, B., Tabuenca, M.-S., Estrada, J. S., Mar�n, F., & Lucas, T. (1993) · Calcified Tissue International · doi:10.1007/bf00571329 · Cited by 40 · see citing works
Terzolo, M., Piovesan, A., Osella, G., Pia, A. R., Reimondo, G., Pozzi, C., Raucci, C., TORTA, M., Paccotti, P., & Angeli, A. (1993) · Calcified Tissue International · doi:10.1007/bf00298716 · Cited by 34 · see citing works
Hyperthyroidism Influences Ultrasound Bone Measurement on the Os Calcis
Gómez Acotto, C., Schott, A. M., Hans, D., Niepomniszcze, H., Mautalen, C. A., & Meunier, P. J. (1998) · Osteoporosis International · doi:10.1007/s001980050091 · Cited by 30 · see citing works
Axial bone mineral density in patients with acromegaly
Bolanowski, M., Wielgus, W., Milewicz, A., & Marciniak, R. (2000) · Academic Radiology · doi:10.1016/s1076-6332(00)80573-5 · Cited by 25 · see citing works
Self-citationBone Ultrasonometry and Turnover Markers in Primary Hyperparathyroidism
Cortet, B., Cortet, C., Blanckaert, F., Racadot, A., D’Herbomez, M., Marchandise, X., & Dewailly, D. (2000) · Calcified Tissue International · doi:10.1007/s002230050004 · Cited by 25 · see citing works
Bone mineral density in acromegaly: Does growth hormone excess protect against osteoporosis?
Chiodini, I., Trischitta, V., Carnevale, V., Liuzzi, A., & Scillitani, A. (2001) · Journal of Endocrinological Investigation · doi:10.1007/bf03343859 · Cited by 19 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Bonadonna, S., Mazziotti, G., Nuzzo, M., Bianchi, A., Fusco, A., Marinis, L. D., & Giustina, A. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.050603 · Cited by 187 · see citing works
Parkinson, C., Kassem, M. S., Heickendorff, L., Flyvbjerg, A., & Trainer, P. J. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030772 · Cited by 88 · see citing works
Bolanowski, M., Daroszewski, J., Mędraś, M., & Zadrożna-Śliwka, B. (2005) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-005-0649-9 · Cited by 74 · see citing works
Self-citationBiochemical bone turnover markers in hormonal disorders in adults: a narrative review
Szulc, P. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01269-7 · Cited by 28 · see citing works
Pituitary Disorders and Osteoporosis
Bolanowski, M., Halupczok, J., & Jawiarczyk-Przybyłowska, A. (2015) · International Journal of Endocrinology · doi:10.1155/2015/206853 · Cited by 27 · see citing works
Self-citationDeterminants of skeletal fragility in acromegaly: a systematic review and meta-analysis
de Moura, C. R., Lopes, S. G. D. C., & Monteiro, A. M. (2022) · Pituitary · doi:10.1007/s11102-022-01256-6 · Cited by 25 · see citing works
Prediction of trabecular bone qualitative properties using scanning quantitative ultrasound
Qin, Y., Lin, W., Mittra, E., Xia, Y., Cheng, J., Judex, S., Rubin, C., & Müller, R. (2012) · Acta Astronautica · doi:10.1016/j.actaastro.2012.08.032 · Cited by 24 · see citing works
Bone densitometry by radiofrequency echographic multi-spectrometry (REMS) in acromegaly patients
Rolla, M., Halupczok-Żyła, J., Jawiarczyk-Przybyłowska, A., & Bolanowski, M. (2020) · Endokrynologia Polska · doi:10.5603/ep.a2020.0056 · Cited by 21 · see citing works
Self-citationUnderstanding the effect of acromegaly on the human skeleton
Bima, C., Chiloiro, S., Mormando, M., Piacentini, S., Bracaccia, E., Giampietro, A., Tartaglione, L., Bianchi, A., & Marinis, L. D. (2016) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2016.1179108 · Cited by 15 · see citing works
Quantitative ultrasound at the hand phalanges in patients with acromegaly
Bolanowski, M., Pluskiewicz, W., Adamczyk, P., & Daroszewski, J. (2006) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2005.10.003 · Cited by 12 · see citing works
Self-citationAcromegaly and ultrasound: how, when and why?
Parolin, M., Dassie, F., Vettor, R., & Maffei, P. (2019) · Journal of Endocrinological Investigation · doi:10.1007/s40618-019-01111-9 · Cited by 12 · see citing works
Bone Properties in Patients with Acromegaly: Quantitative Ultrasound of the Heel
Kaštelan, D., Dušek, T., Kraljević, I., Polašek, O., Perković, Z., Kardum, I., Giljević, Z., Jelčić, J., Aganović, I., & Koršić, M. (2007) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2007.03.103 · Cited by 9 · see citing works
Jawiarczyk-Przybyłowska, A., Halupczok-Żyła, J., Syrycka, J., Zembska, A., Kuliczkowska-Płaksej, J., & Bolanowski, M. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.862845 · Cited by 8 · see citing works
Self-citationSkeletal fragility in pituitary disease: how can we predict fracture risk?
Bioletto, F., Berton, A. M., Barale, M., Aversa, L. S., Sauro, L., Presti, M., Mocellini, F., Sagone, N., Ghigo, E., Massimo, P., et al. (2024) · Pituitary · doi:10.1007/s11102-024-01447-3 · Cited by 7 · see citing works
Novel approach to bone comorbidity in resistant acromegaly
Frara, S., Acanfora, M., Franzese, V., Brandi, M. L., Losa, M., & Giustina, A. (2024) · Pituitary · doi:10.1007/s11102-024-01468-y · Cited by 7 · see citing works
Diagnosis and therapeutic approach to bone health in patients with hypopituitarism
Kuliczkowska-Płaksej, J., Zdrojowy-Wełna, A., Jawiarczyk-Przybyłowska, A., Gojny, Ł., & Bolanowski, M. (2024) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-024-09878-w · Cited by 6 · see citing works
Self-citationOsteoporosis in pituitary diseases: lessons for the clinic
Bolanowski, M., Jawiarczyk-Przybyłowska, A., & Halupczok-Żyła, J. (2014) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2015.983473 · Cited by 5 · see citing works
Self-citationPansini, V., Herbinet, P., Cortet, B., Lefebvre, G., & Cotten, A. (2013) · Elsevier eBooks · doi:10.1016/b978-2-294-71924-0.00010-3 · Cited by 1 · see citing works
Bolanowski, M., Pluskiewicz, W., & Syrycka, J. (2007) · Open Medicine · doi:10.2478/s11536-007-0028-0
Self-citationAcromegalia ed ecografia: uno sguardo nel profondo
Parolin, M., Dassie, F., Vettor, R., & Maffei, P. (2021) · L Endocrinologo · doi:10.1007/s40619-021-00859-8
Campana, C., Casabella, A., Arecco, A., Cutolo, M., Tonelli, S., Hysa, E., Vera, L., Bertaina, F., Amarù, J., Ferone, D., et al. (2026) · Pituitary · doi:10.1007/s11102-026-01696-4
- Authors
- Bolanowski, M., Jędrzejuk, D., Milewicz, A., & Arkowska, A.
- Affiliations
- Wroclaw Medical University (PL)
- Venue
- Osteoporosis International
- Published
- 2002-04
- Volume
- 13
- Issue
- 4
- Pages
- 303-308
- ISSN
- 0937-941X (ISSN-L)
- 1433-2965
- OpenAlex
- W2074498121
- Cited by
- 21
- References
- 23
- Citations by year
- 2026: 1 · 2024: 3 · 2022: 2 · 2021: 1 · 2020: 2 · 2019: 1 · 2016: 1 · 2015: 1 · 2014: 1 · 2013: 1 · 2012: 1
- FWCI
- 1.02
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Osteoporosis International (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Keywords
- quantitative ultrasound, calcaneus, bone turnover, secondary osteoporosis, growth hormone, insulin-like growth factor I, osteocalcin, pyridinoline, bone stiffness, bone mineral density, sex differences, hypogonadism, bone quality, sound velocity, broadband ultrasound attenuation, stiffness index, surgical cure
- MeSH terms
- Acromegaly, Adult, Aged, Amino Acids, Bone Resorption, Calcaneus, Collagen, Female, Humans, Insulin-Like Growth Factor I, Male, Middle Aged, Growth Hormone, Ultrasonography, Biomarkers, Osteocalcin, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review